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Early tooth loss due to cyclic neutropenia: 
long-term follow-up of one patient 
In young patients with abnormal 
loosening of teeth and periodontal 
breakdown, dental professionals 
should consider a wide range of etio- 
logical factors/diseases, analyze dif- 
ferential diagnoses, and make appro- 
priate referrals. The long-term oral 
and dental follow-up of a female 
patient diagnosed in early infancy 
with cyclic neutropenia is reviewed, 
and recommendations for care are 
discussed. 
entists and dental hygienists 
play an important role in the D early detection of diseases or 
conditions whose initial signs are 
seen in the oral cavity. In cases of 
abnormal loosening of teeth and 
periodontal breakdown without an 
apparent cause, the dental profes- 
sional must be prepared to investi- 
gate a wide range of differential diag- 
noses, recommend further investiga- 
tion, and make appropriate referrals. 
Cyclic neutropenia (CN) is charac- 
terized by a transient decrease in the 
neutrophil count, with a periodicity 
of approximately 21 days (range, 14 
to 36 days).',2 It is inherited as an 
autosomal-dominant condition in 
about one-third of the patients, with 
the remaining cases having an 
unclear mode of inheritance.' CN is 
caused by a defect in early 
hematopoietic precursor cell develop- 
ment (more pronounced in the 
myeloid precursors), leading to a 
periodic failure of neutrophil produc- 
tion in the bone rnarrow.lr2 It has also 
been suggested that granulocyte 
colony-stimulating factor (G-CSF) 
production is affected.l.2 Oscillations 
in other hematopoietic elements 
such as monocytes, reticulocytes, and 
platelets are also seen.l.3 
Manifestations of the disease 
appear in early childhood, even 
though it may develop at any age.415 
These manifestations include fever, 
malaise, aphthous stomatitis, skin 
infections, pharyngitis, and lym- 
phadenitis.1-3.6 They typically appear 
one to three days prior to changes in 
the blood count and may persist from 
3 to 10 days.4 Because neutrophils are 
the first line of defense against infec- 
tion, their depletion can be fatal, 
although the child may appear healthy 
between cycles.6 The diagnosis is made 
by documentation of two cycles of 
decreased neutrophil count observed 
in complete blood count (CBC) tests 
done twice weekly for 6 weeks.' 
This report reviews the oral mani- 
festations of CN and presents the case 
of an adult female who has been fol- 
lowed by our pediatric dental service 
since early infancy. 
Case report 
Shortly after birth, in February, 1978, 
our patient had pustular skin infec- 
tions from which Staphylococcus 
uureus was cultured, followed by sev- 
eral episodes of fungal diaper rash 
and otitis media (OM). A CBC 
obtained at 7 months of age, after she 
presented with abscesses on the but- 
tocks, showed a white blood count 
cell (WBC) of 7000/mm3, with a dif- 
ferential count of 40% neutrophils, 
55% lymphocytes, and 5% monocytes 
(for normal blood values, refer to the 
Table). Further studies revealed posi- 
tive myeloperoxidase, normal 
immunoglobulins, normal S. uweus 
bactericidal activity, and normal 
chemotactic migration. Otitis media 
and skin infections continued to 
occur intermittently, and by her first 
birthday, she was placed on daily sul- 
fisoxazole for 3 months, which failed 
to resolve her infections. Fever, neu- 
tropenia, facial cellulitis caused by 
mosquito bites, upper respiratory 
tract infections, infected thumbs, leg 
sores, and oral infections led to multi- 
ple hospitalizations. The patient had 
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Table. Blood count normal reference values.17 
Complete Blood Count Normal Value 
Hemoglobin (g/dl) 
Hematocrit (%) 
White blood cells 
Platelets 
males, 14-18; females, 12-16 
newborns, 16-19; children, 11-16 
males, 40-54; females, 37-47 
newborns, 49-54; children, 35-49 
5000-10,000 cells/mm3 
150,000-400,000 cells/mm3 








Basophils 0-1 % 
Absolute Neutrophil Count (ANC) = WBC x (%segs + % bands) 
difficulties with feeding, toothbrush- 
ing, and taking oral medications 
because of painful mouth ulcers. 
Gingival bleeding, severe gingivitis, 
significant bone loss, and loose pri- 
mary teeth were evident by 2 years of 
age. Because of the oral problems, the 
examining pediatric dentist asked for 
the CBC to be repeated, and it 
revealed abnormalities: hemoglobin = 
8.9 g/dl, platelets = 705,00O/mm3, 
and WBC = 11,80O/mm3, with a dif- 
ferential count of 38% monocytes, 
22% eosinophils, 37% lymphocytes, 
1 % segmented neutrophils, and 1 % 
bands. The majority of the neu- 
trophils showed a lack of maturation. 
After additional blood tests, the 
patient was diagnosed with severe 
congenital CN. She was initially treat- 
ed with steroids, followed by daily 
subcutaneous injections of G-CSF and 
GM-CSF (granulocyte macrophage 
colony-stimulating factor). After the 
growth factors were prescribed, few 
oral lesions have been observed, and 
hospitalizations have decreased to 
about twice a year. 
At age 5, her only remaining teeth 
were the maxillary right second 
molar and the canines. Bone loss was 
uniform, and the family was coun- 
seled about the poor prognosis for 
retaining her permanent dentition. At 
6 years of age, the maxillary left per- 
manent first molar was removed, and 
root caries was noted on both 
mandibular first molars. Despite 
repeated counseling, oral hygiene 
was not optimal at most visits, with 
the gingival tissues consistently 
appearing erythematous, edematous, 
and bleeding on contact. In 
November of 1998, clinical and radi- 
ographic examinations revealed poor 
oral hygiene, generalized periodontal 
breakdown with pocket formation, 
gingival recession, moderate to 
severe mobility of all teeth, severe 
bone loss, and caries (Figs. 1-3). 
Complete exodontia was performed 
uneventfully while the patient was 
under intravenous sedation with 
midazolam hydrochloride and 
ketorolac tromethamine. Before the 
procedure, her blood values were 
WBC = 9900/mm3, hemoglobin = 
11.4 g/dl, hematocrit = 33.8%, 
platelets = ZOO,OOO/mm3, and ANC = 
2.2. She was prescribed clindamycin 
for 10 days, 0.12% chlorhexidine rins- 
es twice daily for a week, and ketoro- 
lac tromethamine for 5 days. After 
adequate tissue healing, complete 
Fig 1. Gingival recession, erythematous and edematous tlssues, 
plaque accumulation. Fig 2. Perlodontal breakdown. 
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dentures were made for her. 
Interestingly, following the extrac- 
tions, her blood counts improved to a 
level not previously seen by her 
hematoIogist. 
Discussion 
In hematologic disorders such as CN, 
prolonged neutropenia and neu- 
trophil dysfunction can lead to life- 
threatening infections.7 Therefore, 
prompt treatment of infections with 
antibiotics and administration of 
hematopoietic growth factors, such as 
G-CSF and GM-CSF, are required.1.2 
Growth factors are glycoproteins that 
stimulate the proliferation of bone 
marrow stem cells and their subse- 
quent maturation into fully differenti- 
ated peripheral blood elements.* G- 
CSF, the critical cytokine for mainte- 
nance of a normal neutrophil count,lO 
also potentiates the functional prop- 
erties of mature cells by increasing 
phagocytic activity, antimicrobial 
killing, and antibody-dependent 
cell-mediated cytoxicity.9 
Neutrophils typically spend 6 days 
from the last stage of cell division 
before entering the circulating 
blood. Daily injections of 30 g of 
G-CSF decreased the interval to 4.5 
days, and 300 g daily further 
reduced the transit time to approxi- 
mately 3 days.” The choice, dosage, 
and administration schedule of 
growth factor should be adjusted to 
maintain the neutrophil counts above 
500/mm3 and to eliminate all infec- 
tions.* Our patient is currently on 
daily injections of 500 g of G-CSF. 
The pediatric dentist who initially 
examined the patient was able to cor- 
relate the clinical picture with a possi- 
ble neutrophil problem, leading to 
further studies that provided the cor- 
rect diagnosis. The oral ulcerations, 
which occurred with a periodicity of 
3 weeks, constituted one of the initial 
manifestations of the disorder. These 
were painful, and could appear in the 
buccal mucosa, lips, tongue, gingiva, 
and pharynx.2~~ The lesions were usu- 
ally present as a central ulceration 
surrounded by erythema and edema, 
with a white coagulum at the base.2 
Use of topical 2% viscous lidocaine 
hydrochloride or dyclonine 
hydrochloride (0.5% or 1.0%) helps 
relieve the oral 
pain. Because 
these are contact 
medications, the 
patients should 
rinse or bathe the 
oral tissues for at 
least 3 minutes; 
otherwise the 
desired effect will 
not be produced. 
Diluting the vis- 
cous lidocaine a 




tions can also be 
applied directly to 
Fig 3. Panoramic radlograph showing extensive bone loss, caries, 
and several missing (extracted) permanent teeth. 
the ulcers with-a cot- 
ton tip if the patient 
is not able to rinse and spit. Gargling 
and swallowing are not advised, 
since loss of gag reflex can result in 
aspiration.12 The rate of mucosal 
absorption of anesthetics is particu- 
larly rapid when open wounds and 
ulcerations are present; hence, the 
abuse of topical anesthetics can lead 
to high blood levels and systemic 
effects such as cardiovascular compli- 
cations and central nervous system 
depression and excitation.13 
Therefore, caregivers and patients 
should be instructed to use topical 
anesthetics with caution (not more 
than once every 30 minutes). At least 
20 minutes should elapse after an 
application before the patient eats a 
meal, to decrease the chance of acci- 
dental trauma. When the neutrophil 
count recovers, the ulcerations heal, 
usually without scarring.5.14 In the 
patient presented here, the boost in 
neutrophil levels triggered by C-CSF 
resulted in a decrease in the frequen- 
cy of oral lesions and an improve- 
ment of nutritional status, leading to 
fewer annual hospital admissions 
and lower treatment costs. 
Because the resistance against 
bacterial infection in patients with 
CN is impaired, rapidly progressive 
periodontal breakdown is 
observed.15 The gingiva are usually 
inflamed, hyperemic, and enlarged, 
with destruction of the interproximal 
papillae (Figs. 1, 2).4 The periodic 
depression of the normal mecha- 
nisms that protect against oral infec- 
tions leads to bone loss with occlusal 
dysfunction and premature loss of 
both primary and permanent teeth, 
as seen in this patient (Fig. 3).3,5,6J4 
Dental therapy was directed at main- 
tenance of optimal oral care in order 
to keep the periodontal tissues 
healthy and delay the loss of alveolar 
bone and teeth for as long as possi- 
ble. Intensive preventive care was 
advocated, with professional pro- 
phylaxis and scaling done every few 
weeks when the CBC was high.15~16 
The caregivers should be educated 
about the role of dental plaque in the 
development and progression of 
periodontal disease. They should be 
trained and periodically re-evaluated 
in their ability to provide adequate 
home care with meticulous plaque 
control through brushing and floss- 
ing, and with chlorhexidine rinses as 
an adjunct. Prescription of fluoride 
rinses or gels should be considered, 
because these patients are at high 
risk for caries due to their often sub- 
optimal oral hygiene and soft diet. 
An important issue for the dental 
professional treating neutropenic 
patients is the development of fungal 
infections, particularly candidiasis, 
which is frequently seen as raised, 
white, curd-like plaque appearing in 
any area of the oral cavity.17 These 
can be scraped off, showing a raw, 
bleeding base.17 The common topical 
medications used to treat candidiasis, 
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such as nystatin rinses and clotrima- 
zole troches, have a high sugar con- 
tent; therefore, the patients should be 
advised about the risk of dental 
caries. Azole agents (ketoconazole, 
clotrimazole, fluconazole) are effec- 
tive as antifungal prophylaxis, while 
nystatin is usually not successful 
when used prophylactically.1*-21 
Intravenous amphotericin B should 
be used only for invasive and sys- 
temic infections.12 
Cooperation from the patients 
and their caregivers must be very 
high for the outcome to be success- 
ful.3915 Antibiotic and corticosteroid 
coverage should be discussed with 
the physician prior to dental proce- 
dures that require invasion of oral 
tissues.4 Placement of restorations 
should be carefully done in order to 
avoid gingival irritation. Intra-oral 
prostheses should be designed not 
to impinge on the soft tissues and 
to facilitate good oral hygiene.4.5 
Splinting of loose teeth should be 
considered carefully to ensure 
integrity of the remaining teeth 
and their supporting  structure^.^'^ 
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